Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:09 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 18,244 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Asthma
Interventions: M CHESS; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 12 Years to 18 Years
Enrollment: 219 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Milwaukee, Wisconsin

Conditions: Distal Radius Fractures
Interventions: Intramedullary Radius Fixation (Micronail), Volar Plate Fixation; Device · Procedure
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Opioid Addiction
Interventions: CRAFT; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 439 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 6
States / cities: Arcata, California • Berkeley, California • Concord, California + 3 more

Conditions: Depression
Interventions: Healthy Minds Program App, Hydro Coach App; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 14 Years to 19 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Vitamin D Deficiency
Interventions: Not listed
Lead sponsor: The Cooper Health System; Other
Eligibility: 18 Years and older
Enrollment: 9,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Cancer
Interventions: Freenome Test; Diagnostic Test
Lead sponsor: Freenome Holdings Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 7,435 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 68
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Springdale, Arkansas + 62 more

Conditions: Heart Failure, Type 2 Diabetes Mellitus
Interventions: Sotagliflozin, Placebo; Drug
Lead sponsor: Lexicon Pharmaceuticals; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 1,222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 94
States / cities: Alexander City, Alabama • Cottonwood, Arizona • Little Rock, Arkansas + 83 more

Conditions: Obesity
Interventions: Behavioral weight loss intervention; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 35 Years
Enrollment: 365 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Multiple Sclerosis
Interventions: Fingolimod 1.25 mg, Fingolimod 0.5 mg, Interferon β-1a 30 µg; Drug
Lead sponsor: Novartis; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 1,292 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 35
States / cities: Cullman, Alabama • Phoenix, Arizona • Oceanside, California + 31 more

Conditions: Actinic Keratosis
Interventions: Carac Cream, Placebo Cetaphil cream; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 90 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Diabetic Foot Ulcer, Type 2 Diabetes
Interventions: Specimen Collection; Other
Lead sponsor: Winthrop University Hospital; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Mineola, New York

Conditions: Musculoskeletal Cancer, Sarcoma,Soft Tissue
Interventions: Tranexamic Acid (TXA); Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cystic Fibrosis
Interventions: VX-661, Ivacaftor, Placebo matched to VX-661, Placebo matched to ivacaftor; Drug
Lead sponsor: Vertex Pharmaceuticals Incorporated; Industry
Eligibility: 12 Years and older
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 19
States / cities: Birmingham, Alabama • Oakland, California • Boise, Idaho + 16 more

Conditions: Multiple Sclerosis
Interventions: Low fat study diet; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Internal Carotid Artery Stenosis, Cognitive Impairment
Interventions: Revascularization, Intensive Medical Management (IMM) alone; Procedure · Other
Lead sponsor: Columbia University; Other
Eligibility: 35 Years to 86 Years
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 56
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 45 more

Conditions: Mild Cognitive Impairment
Interventions: Transcranial alternating current stimulation; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis
Interventions: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014), PedvaxHIB, Prevnar, M-M-R II, Varivax; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Months to 15 Months
Enrollment: 4,021 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 55
States / cities: Birmingham, Alabama • Benton, Arkansas • Jonesboro, Arkansas + 45 more

Conditions: Back Pain
Interventions: Not listed
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 1,760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: QVA149, QAB149, NVA237, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 40 Years and older
Enrollment: 1,042 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 73
States / cities: Birmingham, Alabama • Montgomery, Alabama • Mesa, Arizona + 60 more

Conditions: Forgiveness
Interventions: Forgiveness Therapy, Carey Guides; Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: Male only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Portage, Wisconsin

Conditions: Progressive Keratoconus, Corneal Ectasia
Interventions: Riboflavin, Placebo; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 2
States / cities: Columbus, Ohio • Dublin, Ohio

Conditions: Birth Control, Contraception
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 4,430 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Acute Mountain Sickness (AMS)
Interventions: T89 capsule, Placebo capsule; Drug
Lead sponsor: Tasly Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pregnancy Related, Depression
Interventions: art therapy, nothing; Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Search by objective public record fields.

Mobile CHESS Research on Emergency Medical Services for Children

Fixation of Unstable Distal Radius Fractures

Integrating Support Persons Into Recovery

Well-being Training for Adolescent Depressive Symptoms (TeenWell Study)

Emulated Study of Vitamin D Correction Vs Non-Correction

The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

Cell Phone Intervention in Young Adults

Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase

Cryosurgery and Cream Combination for Actinic Keratosis

Development of a Cellular Biomarker for the Diagnosis and Treatment of Diabetic Foot Ulcers

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation

Low Fat Diet and Multiple Sclerosis

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)

Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

Matching Appropriate Treatments to Consumers' Healthcare Needs, MATCH

A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.

Proposing Forgiveness Therapy Within Prison

Corneal Crosslinking in Keratoconus and Corneal Ectasia

HER Salt Lake Initiative

Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Art Therapy in Obstetric Patients